These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2185327)

  • 1. Prevention of sudden cardiac death: lessons from the cardiac arrhythmia suppression trial (CAST).
    Schlant RC
    J Med Assoc Ga; 1990 Apr; 79(4):245-7. PubMed ID: 2185327
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiac arrhythmia suppression trial (CAST)].
    Furlanello F
    G Ital Cardiol; 1990 Feb; 20(2):171-6. PubMed ID: 2109715
    [No Abstract]   [Full Text] [Related]  

  • 3. Designing clinical trials in the post CAST era--where do we go from here?
    Dorian P
    Can J Cardiol; 1991 Mar; 7(2):105-7; discussion 110-2. PubMed ID: 2049682
    [No Abstract]   [Full Text] [Related]  

  • 4. A critical appraisal of the cardiac arrhythmia suppression trial (CAST).
    Naccarelli GV; Dougherty AH; Wolbrette D; Wiggins S
    Appl Cardiopulm Pathophysiol; 1991; 4(1):9-16. PubMed ID: 10147539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac Arrhythmia Suppression Trial: a disappointment?].
    Magalhães CO
    Arq Bras Cardiol; 1990 Sep; 55(3):153-4. PubMed ID: 2095719
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiarrhythmic agents: current situation].
    Bonhorst D
    Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden cardiac death: risk, evaluation, and primary prevention.
    Tommaso CL; Kehoe RF
    Geriatrics; 1983 Jul; 38(7):42-8, 53. PubMed ID: 6852538
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death].
    Rev Esp Cardiol; 1989 Feb; 42(2):77-83. PubMed ID: 2675221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?].
    Naccarella F; Croci F
    G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ventricular arrhythmias and sudden death: diagnostic, prognostic and therapeutic aspects].
    Van Durme JP
    Verh K Acad Geneeskd Belg; 1981; 43(3):129-84. PubMed ID: 7336827
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-adrenergic blockers in the prevention of sudden death.
    Frishman WH; Laifer LI; Furberg CD
    Cardiovasc Clin; 1985; 15(3):249-64. PubMed ID: 2421902
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of arrhythmias with high risk of sudden death in chronic Chagas' cardiopathy with oral mexiletine. Evaluation with 24-hour ambulatory electrocardiographic monitoring (Holter)].
    Sgammini HO; Evequoz MC; Chuit R; Atti R; Santamarina NO; Kuschnir E
    Arq Bras Cardiol; 1983 Feb; 40(2):103-9. PubMed ID: 6354146
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of antiarrhythmic drugs by sudden death trials.
    Fisher LD
    Circulation; 1986 Feb; 73(2 Pt 2):II98-100. PubMed ID: 3510770
    [No Abstract]   [Full Text] [Related]  

  • 14. [Arrhythmia. Sudden death: a multifactorial pathogenesis that is still a mystery].
    Dagenais G
    Union Med Can; 1990; 119(2):73-4; 79-80. PubMed ID: 2336738
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of antiarrhythmic drugs in prevention of sudden cardiac death.
    Podrid PJ
    Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation and treatment of survivors of sudden cardiac death or nonbradycardic syncope unrelated to coronary artery disease.
    Southworth WF; Ruffy R
    Cardiol Clin; 1983 May; 1(2):275-86. PubMed ID: 6544639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic effects of timolol in patients with ventricular arrhythmias.
    Ribeiro LG; Price BA; Irvin JD
    Arq Bras Cardiol; 1988 Oct; 51(4):359-64. PubMed ID: 3075121
    [No Abstract]   [Full Text] [Related]  

  • 18. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias].
    Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH
    Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sudden death due to arrhythmia without underlying heart disease].
    Kasanuki H; Ohnishi S; Hosoda S
    Kokyu To Junkan; 1989 Mar; 37(3):275-85. PubMed ID: 2734506
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of patients with risk of sudden death. The amiodarone example].
    Djian J
    Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.